Related Experiment Video
Updated: May 18, 2026

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
Published on: July 5, 2022
[Celiac disease: descriptive study at the Anglo American clinic]
O Llanos1, M Matzumura, M Tagle
1Médico Asistente del Servicio de Medicina Interna de la Clínica Anglo Americana. racsollanos@hotmail.com
Celiac disease (CD) diagnosis requires considering gastrointestinal symptoms and extraintestinal manifestations. Initial testing with anti-tissue transglutaminase (anti-TTG) antibodies followed by duodenal biopsy confirms diagnosis and disease staging.
Area of Science:
- Gastroenterology
- Immunology
- Internal Medicine
Background:
- Celiac disease (CD) is an autoimmune disorder triggered by gluten, leading to intestinal damage and malabsorption.
- While globally prevalent at ~1%, its incidence in our country remains unquantified.
Purpose of the Study:
- To determine the prevalence and clinical characteristics of celiac disease in patients presenting with relevant symptoms.
- To evaluate diagnostic methods and histological findings in a cohort of suspected celiac disease patients.
Main Methods:
- A retrospective study analyzed 39 adult patients with positive anti-tissue transglutaminase (anti-TTG) antibody tests.
- Data included medical charts, upper GI endoscopy, and duodenal biopsy reports from September 2004 to February 2012.
Main Results:
- The study included 39 patients (66.7% female), with a mean age of 61.25 years.
- Common symptoms were chronic diarrhea (82.1%), abdominal pain (56.4%), and abdominal distention (35.9%). Anemia was present in 20.5% of patients.
- Duodenal biopsies revealed Marsh classifications III A (51.3%) and III B (30.8%) as the most frequent findings, indicating significant villous atrophy.
Conclusions:
- Celiac disease should be a key differential diagnosis for non-specific chronic gastrointestinal and extraintestinal symptoms.
- Anti-TTG antibody testing is recommended as the initial diagnostic step, followed by duodenal biopsy for confirmation and staging.
Related Concept Videos
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Gastritis III: Clinical Manifestations and Management
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
Chronic Pancreatitis II: Collaborative Care
Assessment:
Inflammatory Bowel Disease IV: Clinical Manifestations
Assessment of the Gastrointestinal System I: Subjective Data
Health History
The initial step in assessing the GI system is obtaining a comprehensive health history. This includes inquiring about the patient's history or presence of problems related to...